NCT07023406 Effectiveness of and Implementation Strategies for 'Disfrutando'.
| NCT ID | NCT07023406 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Missouri-Columbia |
| Condition | Type 2 Diabetes Mellitus (T2DM) |
| Study Type | INTERVENTIONAL |
| Enrollment | 31 participants |
| Start Date | 2025-08-01 |
| Primary Completion | 2026-05-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 31 participants in total. It began in 2025-08-01 with a primary completion date of 2026-05-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Despite much research that has focused on enhancing type 2 diabetes mellitus (T2DM) health outcomes for high burden populations, more remains to be done. There is a need to develop practical approaches that not only equip people with knowledge about T2DM self-management, but also help them mitigate the adverse social determinants of health (SDOH) that are fueling the burgeoning numbers of people in the United States with T2DM and that are preventing them from practicing healthful behaviors. This study will examine an intervention named 'Disfrutando' that strives to help people prevent and manage T2DM.
Eligibility Criteria
Inclusion Criteria: * Hemoglobin A1C of 5.7 or higher Exclusion Criteria: * Hemoglobin A1C of 5.6 or lower
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07023406 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Type 2 Diabetes Mellitus (T2DM). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07023406 currently recruiting?
Yes, NCT07023406 is actively recruiting participants. Contact the research team at enriquezm@missouri.edu for enrollment information.
Where is the NCT07023406 trial being conducted?
This trial is being conducted at Columbia, United States, Kansas City, United States.
Who is sponsoring the NCT07023406 clinical trial?
NCT07023406 is sponsored by University of Missouri-Columbia. The trial plans to enroll 31 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.